Speech-Language Pathologists in Johns Island, SC Accepting Medicare

9 Speech-Language Pathologists found. Showing 1 - 9

Kristen Sterna Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3026 Penny Ln, Johns Island, SC 29455 Phone: 708-525-9359

Amy Terranova Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 60 Fenwick Hall Aly Apt 324, Johns Island, SC 29455 Phone: 225-252-1005

Mrs. Sharon Parham Hite, MED Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4135 Nature View Cir, Johns Island, SC 29455 Phone: 843-559-9633    Fax: 843-559-1813

Holy City Speech, Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1753 Clark Hills Cir, Johns Island, SC 29455 Phone: 815-514-5500

Say It With A Smile Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2932 Sweetleaf Ln, Johns Island, SC 29455 Phone: 843-345-5159

Mrs. Valerie Ann Kroesen, M.S. CCC-SLP NBTC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1035 Sweetwater Dr, Johns Island, SC 29455 Phone: 843-559-4588    Fax: 843-899-8890

Mrs. Dixie Barkand, MS, CCC Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 2770 Maybank Hwy, Ste E, Johns Island, SC 29455 Phone: 843-559-7599    Fax: 843-559-1381

Southern Speech Therapy Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3026 Penny Ln, Johns Island, SC 29455 Phone: 708-525-9359

Olivia Cecile Harnois, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 60 Fenwick Hall Aly Apt 825, Johns Island, SC 29455 Phone: 603-489-7059

News Archive

NIH-funded study examines most effective treatment option for pregnancy of unknown location

Preemptive treatment for a nonviable pregnancy of unknown location—a situation in which there is a positive pregnancy test result but the location of the pregnancy cannot be confirmed within or outside the uterus with other diagnostic tests—resolves the condition more rapidly than treating symptoms as they arise, suggests a study supported by the National Institutes of Health.

CarThera receives €5.7 million grant for DOME project from France's Investments for the Future Program

CarThera, which designs and develops innovative medical devices to treat brain disorders, today announces it has received a grant of €5.7 million ($6.4m) for its DOME project.

Biomoda, Obio sign MOU to establish CLIA-certified clinical laboratory in Ohio

Cancer diagnostics company Biomoda, Inc. and Obio, a corporation formed to pursue public and private funding for cancer research in Ohio, signed a memorandum of understanding to establish a CLIA-certified Biomoda clinical laboratory in Ohio to support ongoing research and development on Biomoda's porphyrin-based assay for the detection of early-stage cancer.

ZymoGenetics announces pricing of public offering of 14,000,000 shares

ZymoGenetics, Inc. today announced that it has priced an underwritten public offering of 14,000,000 shares of its common stock at a price of $6.00 per share. Net proceeds, after estimated underwriting discounts and commissions and estimated expenses, will be approximately $79,000,000.

Read more Medical News

› Verified 5 days ago